Assessment of aortic valve disease : role of imaging modalities

DC FieldValueLanguage
dc.contributor.authorCapoulade, Romain-
dc.contributor.authorPibarot, Philippe-
dc.date.accessioned2016-06-07T15:31:52Z-
dc.date.available10000-01-01-
dc.date.issued2015-09-22-
dc.identifier.issn1092-8464fr_CA
dc.identifier.urihttp://hdl.handle.net/20.500.11794/3508-
dc.description.abstractAortic valve disease, which includes aortic valve stenosis (AS) and/or regurgitation (AR), is the most prevalent cardiovascular disease after hypertension and coronary artery disease. Imaging modalities are essential for the staging and management of aortic valve disease. Transthoracic echocardiography (TTE) is the primary imaging modality that is used in clinical practice to assess the aortic valve morphology, the severity of aortic valve disease, and its repercussions on left ventricular (LV) function and pulmonary arterial circulation. Exercise testing and exercise stress echocardiography should be considered in patients with asymptomatic severe aortic valve disease in order to enhance risk stratification and eventually recommend early valve replacement intervention. Three-dimensional (3D) imaging modalities including 3D echocardiography, multidetector computed tomography (MDCT), or cardiac magnetic resonance (CMR) may help to improve the accuracy of the parameters of valve disease severity and LV function. Dobutamine stress echocardiography and, more recently, aortic valve calcium scoring by MDCT have been shown to be useful to confirm stenosis severity in the challenging subsets of patients with low-flow, low-gradient AS. In conclusion, we believe that 3D echocardiography, stress echocardiography, and MDCT are now ready for prime time in clinical practice, and a more systematic but rationale utilization of these modalities should thus be considered in patients with aortic valve disease. Other imaging modalities such as CMR for the assessment of myocardial fibrosis or positron emission tomography for the assessment of valve mineralization activity have been shown to be promising to predict disease progression and outcomes, but further research is necessary before implementation of these modalities into clinical practice.fr_CA
dc.languageengfr_CA
dc.publisherCurrent Science, Inc.fr_CA
dc.subjectAortic valve diseasefr_CA
dc.subjectImagingfr_CA
dc.subjectDoppler-echocardiographyfr_CA
dc.subjectCardiac magnetic resonancefr_CA
dc.subjectMultidetector computed tomographyfr_CA
dc.subject3D echocardiographyfr_CA
dc.titleAssessment of aortic valve disease : role of imaging modalitiesfr_CA
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherche-
dcterms.bibliographicCitationCurrent Treatment Options in Cardiovascular Medicine, Vol. 17 (11), 1-17 (2015)fr_CA
dc.audienceProfesseurs (Enseignement supérieur)fr_CA
dc.audienceÉtudiantsfr_CA
dc.audienceDoctorantsfr_CA
dc.audienceMédecinsfr_CA
dc.identifier.doi10.1007/s11936-015-0409-7fr_CA
dc.identifier.pubmed26391799fr_CA
dc.subject.rvmValvule semi-lunaire de l'ostium aortique -- Maladies -- Imageriefr_CA
dc.subject.rvmÉchocardiographie Dopplerfr_CA
dc.subject.rvmCœur -- Imagerie par résonance magnétiquefr_CA
dc.subject.rvmTomodensitométriefr_CA
dc.subject.rvmÉchocardiographie tridimensionnellefr_CA
dc.subject.rvmÉchocardiographie de stressfr_CA
rioxxterms.versionVersion of Recordfr_CA
rioxxterms.version_of_recordhttps://doi.org/10.1007/s11936-015-0409-7fr_CA
rioxxterms.project.funder_nameirscfr_CA
bul.rights.periodeEmbargoInfinifr_CA
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
Capoulade2015-15239.pdf
1.34 MBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.